Helicobacter pylori infection and inflammatory bowel disease: Is there a link?

World Journal of Gastroenterology

Volumn 20, Issue 21, 2014, Pages 6374-6385

  Papamichael, Konstantinos ^a   Konstantopoulos, Panagiotis ^a   Mantzaris, Gerassimos J ^a  

^a EVANGELISMOS HOSPITAL   (Greece)

Author keywords

Colorectal cancer; Crohn's disease; Helicobacter pylori; Inflammatory bowel disease; Ulcerative colitis

Indexed keywords

CIPROFLOXACIN; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 18; INTERLEUKIN 1BETA; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; INTERLEUKIN 7; INTERLEUKIN 8; MESALAZINE; METRONIDAZOLE; SALAZOSULFAPYRIDINE; TUMOR NECROSIS FACTOR;

ARTICLE; AUTOIMMUNITY; BACTERIAL CLEARANCE; COLORECTAL CANCER; CROHN DISEASE; DISEASE ASSOCIATION; DISEASE COURSE; HELICOBACTER; HELICOBACTER INFECTION; HUMAN; INFECTION CONTROL; INFLAMMATORY BOWEL DISEASE; META ANALYSIS (TOPIC); NONHUMAN; PROTECTION; ULCERATIVE COLITIS; COLORECTAL TUMOR; COMORBIDITY; COMPLICATION; GASTRITIS; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; IMMUNE SYSTEM; MICROBIOLOGY; PREVALENCE;

COLITIS, ULCERATIVE; COLORECTAL NEOPLASMS; COMORBIDITY; CROHN DISEASE; GASTRITIS; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; IMMUNE SYSTEM; INFLAMMATORY BOWEL DISEASES; PREVALENCE;

EID: 84902078896     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v20.i21.6374     Document Type: Article

References (147)

1. Loftus EV. Clinical epidemiology of inflammatory bowel disease: Incidence, prevalence, and environmental influences. Gastroenterology 2004; 126: 1504-1517 [PMID: 15168363 DOI: 10.1053/j.gastro.2004.01.063]
2. Buchner AM, Blonski W, Lichtenstein GR. Update on the management of Crohn's disease. Curr Gastroenterol Rep 2011; 13: 465-474 [PMID: 21792543 DOI: 10.1007/s11894-011- 0220-x]
3. Baumgart DC, Bernstein CN, Abbas Z, Colombel JF, Day AS, D'Haens G, Dotan I, Goh KL, Hibi T, Kozarek RA, Quigley EM, Reinisch W, Sands BE, Sollano JD, Steinhart AH, Steinwurz F, Vatn MH, Yamamoto-Furusho JK. IBD Around the world: comparing the epidemiology, diagnosis, and treatment: proceedings of the World Digestive Health Day 2010--Inflammatory Bowel Disease Task Force meeting. Inflamm Bowel Dis 2011; 17: 639-644 [PMID: 20725944 DOI: 10.1002/ibd.21409]
4. Podolsky DK. Inflammatory bowel disease (1) N Engl J Med 1991; 325: 928-937 [PMID: 1881418 DOI: 10.1056/ NEJM199109263251306]
5. MacDonald TT, Murch SH. Aetiology and pathogenesis of chronic inflammatory bowel disease. Baillieres Clin Gastroenterol 1994; 8: 1-34 [PMID: 8003737 DOI: 10.1016/ S0950-3528(06)80017-5]
6. Elson CO. Genes, microbes, and T cells--new therapeutic targets in Crohn's disease. N Engl J Med 2002; 346: 614-616 [PMID: 11856802 DOI: 10.1056/NEJM200202213460812]
7. Cleynen I, Vazeille E, Artieda M, Verspaget HW, Szczypiorska M, Bringer MA, Lakatos PL, Seibold F, Parnell K, Weersma RK, Mahachie John JM, Morgan-Walsh R, Staelens D, Arijs I, De Hertogh G, Müller S, Tordai A, Hommes DW, Ahmad T, Wijmenga C, Pender S, Rutgeerts P, Van Steen K, Lottaz D, Vermeire S, Darfeuille-Michaud A. Genetic and microbial factors modulating the ubiquitin proteasome system in inflammatory bowel disease. Gut 2013; Epub ahead of print [PMID: 24092863 DOI: 10.1136/gutjnl-2012-303205]
8. Gradel KO, Nielsen HL, Schønheyder HC, Ejlertsen T, Kristensen B, Nielsen H. Increased short- and long-term risk of inflammatory bowel disease after salmonella or campylobacter gastroenteritis. Gastroenterology 2009; 137: 495-501 [PMID: 19361507 DOI: 10.1053/j.gastro.2009.04.001]
9. Sonnenberg A. Review article: historic changes of Helicobacter pylori-associated diseases. Aliment Pharmacol Ther 2013; 38: 329-342 [PMID: 23786250 DOI: 10.1111/apt.12380]
10. Keenan JI, Beaugie CR, Jasmann B, Potter HC, Collett JA, Frizelle FA. Helicobacter species in the human colon. Colorectal Dis 2010; 12: 48-53 [PMID: 20050183 DOI: 10.1111/ j.1463-1318.2008.01672.x]
11. Kelly SM, Pitcher MC, Farmery SM, Gibson GR. Isolation of Helicobacter pylori from feces of patients with dyspepsia in the United Kingdom. Gastroenterology 1994; 107: 1671-1674 [PMID: 7958677]
12. Kabir S. Detection of Helicobacter pylori in faeces by culture, PCR and enzyme immunoassay. J Med Microbiol 2001; 50: 1021-1029 [PMID: 11761185 DOI: 10.1111/ j.1083-4389.2004.00207.x]
13. Kabir S. Detection of Helicobacter pylori DNA in feces and saliva by polymerase chain reaction: a review. Helicobacter 2004; 9: 115-123 [PMID: 15068412]
14. Papamichael K, Mantzaris GJ. Pathogenesis of helicobacter pylori infection: colonization, virulence factors of the bacterium and immune and non-immune host response. Hospital Chronicles 2012; 7: 110-116
15. Valle J, Kekki M, Sipponen P, Ihamäki T, Siurala M. Longterm course and consequences of Helicobacter pylori gastritis. Results of a 32-year follow-up study. Scand J Gastroenterol 1996; 31: 546-550 [PMID: 8789892 DOI: 10.3109/00365529609 009126]
16. Smythies LE, Waites KB, Lindsey JR, Harris PR, Ghiara P, Smith PD. Helicobacter pylori-induced mucosal inflammation is Th1 mediated and exacerbated in IL-4, but not IFNgamma, gene-deficient mice. J Immunol 2000; 165: 1022-1029 [PMID: 10878379]
17. Di Tommaso A, Xiang Z, Bugnoli M, Pileri P, Figura N, Bayeli PF, Rappuoli R, Abrignani S, De Magistris MT. Helicobacter pylori-specific CD4+ T-cell clones from peripheral blood and gastric biopsies. Infect Immun 1995; 63: 1102-1106 [PMID: 7868233]
18. Meyer F, Wilson KT, James SP. Modulation of innate cytokine responses by products of Helicobacter pylori. Infect Immun 2000; 68: 6265-6272 [PMID: 11035734 DOI: 10.1128/ IAI.68.11.6265-6272.2000]
19. van Amsterdam K, van Vliet AH, Kusters JG, van der Ende A. Of microbe and man: determinants of Helicobacter pylorirelated diseases. FEMS Microbiol Rev 2006; 30: 131-156 [PMID: 16438683 DOI: 10.1111/j.1574-6976.2005.00006.x]
20. Papamichael KX, Papaioannou G, Karga H, Roussos A, Mantzaris GJ. Helicobacter pylori infection and endocrine disorders: is there a link? World J Gastroenterol 2009; 15: 2701-2707 [PMID: 19522019 DOI: 10.3748/wjg.15.2701]
21. Ram M, Barzilai O, Shapira Y, Anaya JM, Tincani A, Stojanovich L, Bombardieri S, Bizzaro N, Kivity S, Agmon Levin N, Shoenfeld Y. Helicobacter pylori serology in autoimmune diseases - fact or fiction? Clin Chem Lab Med 2013; 51: 1075-1082 [PMID: 23079514 DOI: 10.1515/cclm-2012-0477]
22. Reibman J, Marmor M, Filner J, Fernandez-Beros ME, Rogers L, Perez-Perez GI, Blaser MJ. Asthma is inversely associated with Helicobacter pylori status in an urban population. PLoS One 2008; 3: e4060 [PMID: 19112508 DOI: 10.1371/journal. pone.0004060]
23. Krause I, Anaya JM, Fraser A, Barzilai O, Ram M, Abad V, Arango A, García J, Shoenfeld Y. Anti-infectious antibodies and autoimmune-associated autoantibodies in patients with type I diabetes mellitus and their close family members. Ann N Y Acad Sci 2009; 1173: 633-639 [PMID: 19758209 DOI: 10.1111/j.1749-6632.2009.04619.x]
24. Perri F, Clemente R, Festa V, De Ambrosio CC, Quitadamo M, Fusillo M, Grossi E, Andriulli A. Serum tumour necrosis factor-alpha is increased in patients with Helicobacter pylori infection and CagA antibodies. Ital J Gastroenterol Hepatol 1999; 31: 290-294 [PMID: 10425573]
25. Kwon JH, Keates S, Bassani L, Mayer LF, Keates AC. Colonic epithelial cells are a major site of macrophage inflammatory protein 3alpha (MIP-3alpha) production in normal colon and inflammatory bowel disease. Gut 2002; 51: 818-826 [PMID: 12427784 DOI: 10.1136/gut.51.6.818]
26. Koloski NA, Bret L, Radford-Smith G. Hygiene hypothesis in inflammatory bowel disease: a critical review of the literature. World J Gastroenterol 2008; 14: 165-173 [PMID: 18186549 DOI: 10.3748/wjg.14.165]
27. Atherton JC, Blaser MJ. Helicobacter pylori infections. In: Harrison's Principles of Internal Medicine. 16th ed. New York: McGraw-Hill, 2005: 886
28. Thia KT, Loftus EV, Sandborn WJ, Yang SK. An update on the epidemiology of inflammatory bowel disease in Asia. Am J Gastroenterol 2008; 103: 3167-3182 [PMID: 19086963 DOI: 10.1111/j.1572-0241.2008.02158.x]
29. Pearce CB, Duncan HD, Timmis L, Green JR. Assessment of the prevalence of infection with Helicobacter pylori in patients with inflammatory bowel disease. Eur J Gastroenterol Hepatol 2000; 12: 439-443 [PMID: 10783998 DOI: 10.1097/000 42737-200012040-00012]
30. Duggan AE, Usmani I, Neal KR, Logan RF. Appendicectomy, childhood hygiene, Helicobacter pylori status, and risk of inflammatory bowel disease: a case control study. Gut 1998; 43: 494-498 [PMID: 9824576 DOI: 10.1136/gut.43.4.494]
31. Feeney MA, Murphy F, Clegg AJ, Trebble TM, Sharer NM, Snook JA. A case-control study of childhood environmental risk factors for the development of inflammatory bowel disease. Eur J Gastroenterol Hepatol 2002; 14: 529-534 [PMID: 11984151 DOI: 10.1097/00042737-200205000-00010]
32. el-Omar E, Penman I, Cruikshank G, Dover S, Banerjee S, Williams C, McColl KE. Low prevalence of Helicobacter pylori in inflammatory bowel disease: association with sulphasalazine. Gut 1994; 35: 1385-1388 [PMID: 7959192 DOI: 10.1136/gut.35.10.1385]
33. D'Incà R, Sturniolo G, Cassaro M, di Pace C, Longo G, Callegari I, Rugge M. Prevalence of upper gastrointestinal lesions and Helicobacter pylori infection in Crohn's disease. Dig Dis Sci 1998; 43: 988-992 [PMID: 9590412 DOI: 10.1023/A: 1018870415898]
34. Parente F, Molteni P, Bollani S, Maconi G, Vago L, Duca PG, Rembacken B, Axon AT, Bianchi Porro G. Prevalence of Helicobacter pylori infection and related upper gastrointestinal lesions in patients with inflammatory bowel diseases. A cross-sectional study with matching. Scand J Gastroenterol 1997; 32: 1140-1146 [PMID: 9399396 DOI: 10.3109/003655297 09002994]
35. Piodi LP, Bardella M, Rocchia C, Cesana BM, Baldassarri A, Quatrini M. Possible protective effect of 5-aminosalicylic acid on Helicobacter pylori infection in patients with inflammatory bowel disease. J Clin Gastroenterol 2003; 36: 22-25 [PMID: 12488702 DOI: 10.1097/00004836-200301000-00008]
36. Pellicano R, Bresso F, Demarchi B, Bertolusso L, Sapone N, Rizzetto M, Astegiano M. Prevalence of Helicobacter pylori infection in patients with inflammatory bowel disease: pilot study. Rev Esp Enferm Dig 2010; 102: 675-66author reply 676 [PMID: 21142397]
37. Parlak E, Ulker A, Dişibeyaz S, Alkim C, Daǧli U. There is no significant increase in the incidence of Helicobacter pylori infection in patients with inflammatory bowel disease in Turkey. J Clin Gastroenterol 2001; 33: 87-88 [PMID: 11418804 DOI: 10.1097/00004836-200107000-00025]
38. Mantzaris GJ, Archavlis E, Zografos C, Zavos K, Petraki K, Triadaphyllou G. Low prevalence of Helicobacter pylori in inflammatory bowel disease: association with sulfasalazine. Am J Gastroenterol 1995; 90: 1900 [PMID: 7572928]
39. Triantafillidis JK, Gikas A, Apostolidiss N, Merikas E, Mallass E, Peros G. The low prevalence of helicobacter infection in patients with inflammatory bowel disease could be attributed to previous antibiotic treatment. Am J Gastroenterol 2003; 98: 1213-1214 [PMID: 12809861 DOI: 10.1111/ j.1572-0241.2003.07434.x]
40. Kolho KL, Rautelin H, Lindahl H, Savilahti E. Helicobacter pylori-positive gastritis in pediatric patients with chronic inflammatory bowel disease. J Pediatr Gastroenterol Nutr 1998; 27: 292-295 [PMID: 9740199 DOI: 10.1097/00005176-19980900 0-00004]
41. Väre PO, Heikius B, Silvennoinen JA, Karttunen R, Niemelä SE, Lehtola JK, Karttunen TJ. Seroprevalence of Helicobacter pylori infection in inflammatory bowel disease: is Helicobacter pylori infection a protective factor? Scand J Gastroenterol 2001; 36: 1295-1300 [PMID: 11761020 DOI: 10.1080/0036 55201317097155]
42. Halme L, Rautelin H, Leidenius M, Kosunen TU. Inverse correlation between Helicobacter pylori infection and inflammatory bowel disease. J Clin Pathol 1996; 49: 65-67 [PMID: 8666689 DOI: 10.1136/jcp.49.1.65]
43. Song MJ, Park DI, Hwang SJ, Kim ER, Kim YH, Jang BI, Lee SH, Ji JS, Shin SJ. The prevalence of Helicobacter pylori in- fection in Korean patients with inflammatory bowel disease, a multicenter study. Korean J Gastroenterol 2009; 53: 341-347 [PMID: 19556840 DOI: 10.4166/kjg.2009.53.6.341]
44. Wagtmans MJ, Witte AM, Taylor DR, Biemond I, Veenendaal RA, Verspaget HW, Lamers CB, van Hogezand RA. Low seroprevalence of Helicobacter pylori antibodies in historical sera of patients with Crohn's disease. Scand J Gastroenterol 1997; 32: 712-718 [PMID: 9246713 DOI: 10.3109/ 00365529708996523]
45. Matsumura M, Matsui T, Hatakeyama S, Matake H, Uno H, Sakurai T, Yao T, Oishi T, Iwashita A, Fujioka T. Prevalence of Helicobacter pylori infection and correlation between severity of upper gastrointestinal lesions and H. pylori infection in Japanese patients with Crohn's disease. J Gastroenterol 2001; 36: 740-747 [PMID: 11757745 DOI: 10.1007/ s005350170015]
46. Ando T, Watanabe O, Ishiguro K, Maeda O, Ishikawa D, Minami M, Hasegawa M, Kondo S, Goto Y, Ohmiya N, Niwa Y, Goto H. Relationships between Helicobacter pylori infection status, endoscopic, histopathological findings, and cytokine production in the duodenum of Crohn's disease patients. J Gastroenterol Hepatol 2008; 23 Suppl 2: S193-S197 [PMID: 19120897 DOI: 10.1111/j.1440-1746.2008.05438.x]
47. Lidar M, Langevitz P, Barzilai O, Ram M, Porat-Katz BS, Bizzaro N, Tonutti E, Maieron R, Chowers Y, Bar-Meir S, Shoenfeld Y. Infectious serologies and autoantibodies in inflammatory bowel disease: insinuations at a true pathogenic role. Ann N Y Acad Sci 2009; 1173: 640-648 [PMID: 19758210 DOI: 10.1111/j.1749-6632.2009.04673.x]
48. Prónai L, Schandl L, Orosz Z, Magyar P, Tulassay Z. Lower prevalence of Helicobacter pylori infection in patients with inflammatory bowel disease but not with chronic obstructive pulmonary disease - antibiotic use in the history does not play a significant role. Helicobacter 2004; 9: 278-283 [PMID: 15165265]
49. Meining A, Bayerdörffer E, Bastlein E, Raudis N, Thiede C, Cyrus B, Krämer W, Klann H, Labenz J, Stolte M. Focal inflammatory infiltrations in gastric biopsy specimens are suggestive of Crohn's disease. Crohn's Disease Study Group, Germany. Scand J Gastroenterol 1997; 32: 813-818 [PMID: 9282974]
50. Oberhuber G, Püspök A, Oesterreicher C, Novacek G, Zauner C, Burghuber M, Vogelsang H, Pötzi R, Stolte M, Wrba F. Focally enhanced gastritis: a frequent type of gastritis in patients with Crohn's disease. Gastroenterology 1997; 112: 698-706 [PMID: 9041230]
51. Pascasio JM, Hammond S, Qualman SJ. Recognition of Crohn disease on incidental gastric biopsy in childhood. Pediatr Dev Pathol 2003; 6: 209-214 [PMID: 12658540]
52. Sonnenberg A, Genta RM. Low prevalence of Helicobacter pylori infection among patients with inflammatory bowel disease. Aliment Pharmacol Ther 2012; 35: 469-476 [PMID: 22221289 DOI: 10.1111/j.1365-2036.2011.04969.x]
53. Oliveira AG, das Graças Pimenta Sanna M, Rocha GA, Rocha AM, Santos A, Dani R, Marinho FP, Moreira LS, de Lourdes Abreu Ferrari M, Moura SB, Castro LP, Queiroz DM. Helicobacter species in the intestinal mucosa of patients with ulcerative colitis. J Clin Microbiol 2004; 42: 384-386 [PMID: 14715785]
54. Oliveira AG, Rocha GA, Rocha AM, Sanna Md, Moura SB, Dani R, Marinho FP, Moreira LS, Ferrari Mde L, Castro LP, Queiroz DM. Isolation of Helicobacter pylori from the intestinal mucosa of patients with Crohn's disease. Helicobacter 2006; 11: 2-9 [PMID: 16423084]
55. Sładek M, Jedynak-Wasowicz U, Wedrychowicz A, Kowalska- Duplaga K, Pieczarkowski S, Fyderek K. The low prevalence of Helicobacter pylori gastritis in newly diagnosed inflammatory bowel disease children and adolescent. Przegl Lek 2007; 64 Suppl 3: 65-67 [PMID: 18431918]
56. Garza-González E, Pérez-Pérez GI, Mendoza-Ibarra SI, Flores-Gutiérrez JP, Bosques-Padilla FJ. Genetic risk factors for inflammatory bowel disease in a North-eastern Mexican population. Int J Immunogenet 2010; 37: 355-359 [PMID: 20518842 DOI: 10.1111/j.1744-313X.2010.00932.x]
57. Zhang S, Zhong B, Chao K, Xiao Y, Cui Y, Gao X, Chen B, He Y, Hu P, Chen M, Mitchell HM. Role of Helicobacter species in Chinese patients with inflammatory bowel disease. J Clin Microbiol 2011; 49: 1987-1989 [PMID: 21346040 DOI: 10.1128/JCM.02630-10]
58. Xiang Z, Chen YP, Ye YF, Ma KF, Chen SH, Zheng L, Yang YD, Jin X. Helicobacter pylori and Crohn's disease: a retrospective single-center study from China. World J Gastroenterol 2013; 19: 4576-4581 [PMID: 23901235 DOI: 10.3748/wjg.v19. i28.4576]
59. Jin X, Chen YP, Chen SH, Xiang Z. Association between Helicobacter Pylori infection and ulcerative colitis--a case control study from China. Int J Med Sci 2013; 10: 1479-1484 [PMID: 24046521 DOI: 10.7150/ijms.6934]
60. Varas-Lorenzo MJ, Muñoz-Agel F. [Is Helicobacter pylori active infection increased or decreased in Crohn's disease?]. Rev Esp Enferm Dig 2010; 102: 509-510 [PMID: 20670077]
61. Hong CH, Park DI, Choi WH, Park JH, Kim HJ, Cho YK, Sohn CI, Jeon WK, Kim BI, Kim DH, Kim MK, Chae SW, Lee KB, Sohn JH, Oh SJ. The clinical usefulness of focally enhanced gastritis in Korean patients with Crohn's disease. Korean J Gastroenterol 2009; 53: 23-28 [PMID: 19158467]
62. Roka K, Roma E, Stefanaki K, Panayotou I, Kopsidas G, Chouliaras G. The value of focally enhanced gastritis in the diagnosis of pediatric inflammatory bowel diseases. J Crohns Colitis 2013; 7: 797-802 [PMID: 23207168 DOI: 10.1016/ j.crohns.2012.11.003]
63. Sonnenberg A, Melton SD, Genta RM. Frequent occurrence of gastritis and duodenitis in patients with inflammatory bowel disease. Inflamm Bowel Dis 2011; 17: 39-44 [PMID: 20848539 DOI: 10.1002/ibd.21356]
64. Halme L, Kärkkäinen P, Rautelin H, Kosunen TU, Sipponen P. High frequency of helicobacter negative gastritis in patients with Crohn's disease. Gut 1996; 38: 379-383 [PMID: 8675090]
65. Lundgren A, Strömberg E, Sjöling A, Lindholm C, Enarsson K, Edebo A, Johnsson E, Suri-Payer E, Larsson P, Rudin A, Svennerholm AM, Lundin BS. Mucosal FOXP3-expressing CD4+ CD25high regulatory T cells in Helicobacter pyloriinfected patients. Infect Immun 2005; 73: 523-531 [PMID: 15618192]
66. Rad R, Brenner L, Bauer S, Schwendy S, Layland L, da Costa CP, Reindl W, Dossumbekova A, Friedrich M, Saur D, Wagner H, Schmid RM, Prinz C. CD25+/Foxp3+ T cells regulate gastric inflammation and Helicobacter pylori colonization in vivo. Gastroenterology 2006; 131: 525-537 [PMID: 16890606]
67. Wehkamp J, Fellermann K, Herrlinger KR, Bevins CL, Stange EF. Mechanisms of disease: defensins in gastrointestinal diseases. Nat Clin Pract Gastroenterol Hepatol 2005; 2: 406-415 [PMID: 16265431]
68. Sonnenberg A. Protective role of Helicobacter pylori against inflammatory bowel disease: a hypothesis. Pract Gastroenterol 2009; 33: 23-33
69. Kullberg MC, Ward JM, Gorelick PL, Caspar P, Hieny S, Cheever A, Jankovic D, Sher A. Helicobacter hepaticus triggers colitis in specific-pathogen-free interleukin-10 (IL-10)- deficient mice through an IL-12- and gamma interferondependent mechanism. Infect Immun 1998; 66: 5157-5166 [PMID: 9784517]
70. Shomer NH, Dangler CA, Schrenzel MD, Fox JG. Helicobacter bilis-induced inflammatory bowel disease in scid mice with defined flora. Infect Immun 1997; 65: 4858-4864 [PMID: 9353076]
71. Monceaux CP, Traci L. Testerman, Moheb Boktor, Paul Jordan, Patrick Adegboyega, David J. McGee, Merilyn H. Jennings, Courtney P. Parker, Shelly Gupta, Ping Yi, Vijay C. Ganta, Haidy Galous, Kenneth Manas, J. Steven Alexander. Helicobacter infection decreases basal colon inflammation, but increases disease activity in experimental IBD. Open J Gastroenterol 2013; 3: 177-189 [DOI: 10.4236/ojgas.2013.33029]
72. Jiang HQ, Kushnir N, Thurnheer MC, Bos NA, Cebra JJ. Monoassociation of SCID mice with Helicobacter muridarum, but not four other enterics, provokes IBD upon receipt of T cells. Gastroenterology 2002; 122: 1346-1354 [PMID: 11984521 DOI: 10.1053/gast.2002.32959]
73. Jergens AE, Wilson-Welder JH, Dorn A, Henderson A, Liu Z, Evans RB, Hostetter J, Wannemuehler MJ. Helicobacter bilis triggers persistent immune reactivity to antigens derived from the commensal bacteria in gnotobiotic C3H/HeN mice. Gut 2007; 56: 934-940 [PMID: 17145736]
74. Zhang L, Danon SJ, Grehan M, Chan V, Lee A, Mitchell H. Natural colonization with Helicobacter species and the development of inflammatory bowel disease in interleukin- 10-deficient mice. Helicobacter 2005; 10: 223-230 [PMID: 15904480 DOI: 10.1111/j.1523-5378.2005.00314.x]
75. Hansen R, Thomson JM, Fox JG, El-Omar EM, Hold GL. Could Helicobacter organisms cause inflammatory bowel disease? FEMS Immunol Med Microbiol 2011; 61: 1-14 [PMID: 20955468 DOI: 10.1111/j.1574-695X.2010.00744.x]
76. Fox JG, Boutin SR, Handt LK, Taylor NS, Xu S, Rickman B, Marini RP, Dewhirst FE, Paster BJ, Motzel S, Klein HJ. Isolation and characterization of a novel helicobacter species, "Helicobacter macacae," from rhesus monkeys with and without chronic idiopathic colitis. J Clin Microbiol 2007; 45: 4061-4063 [PMID: 17928421]
77. Laharie D, Asencio C, Asselineau J, Bulois P, Bourreille A, Moreau J, Bonjean P, Lamarque D, Pariente A, Soulé JC, Charachon A, Coffin B, Perez P, Mégraud F, Zerbib F. Association between entero-hepatic Helicobacter species and Crohn's disease: a prospective cross-sectional study. Aliment Pharmacol Ther 2009; 30: 283-293 [PMID: 19438427 DOI: 10.1111/j.1365-2036.2009.04034.x]
78. Man SM, Zhang L, Day AS, Leach S, Mitchell H. Detection of enterohepatic and gastric helicobacter species in fecal specimens of children with Crohn's disease. Helicobacter 2008; 13: 234-238 [PMID: 18665930 DOI: 10.1111/ j.1523-5378.2008.00607.x]
79. Zhang L, Day A, McKenzie G, Mitchell H. Nongastric Helicobacter species detected in the intestinal tract of children. J Clin Microbiol 2006; 44: 2276-2279 [PMID: 16757639]
80. Kaakoush NO, Holmes J, Octavia S, Man SM, Zhang L, Castaño-Rodríguez N, Day AS, Leach ST, Lemberg DA, Dutt S, Stormon M, O'Loughlin EV, Magoffin A, Mitchell H. Detection of Helicobacteraceae in intestinal biopsies of children with Crohn's disease. Helicobacter 2010; 15: 549-557 [PMID: 21073612 DOI: 10.1111/j.1523-5378.2010.00792.x]
81. Bohr UR, Glasbrenner B, Primus A, Zagoura A, Wex T, Malfertheiner P. Identification of enterohepatic Helicobacter species in patients suffering from inflammatory bowel disease. J Clin Microbiol 2004; 42: 2766-2768 [PMID: 15184464]
82. Thomson JM, Hansen R, Berry SH, Hope ME, Murray GI, Mukhopadhya I, McLean MH, Shen Z, Fox JG, El-Omar E, Hold GL. Enterohepatic helicobacter in ulcerative colitis: potential pathogenic entities? PLoS One 2011; 6: e17184 [PMID: 21383845 DOI: 10.1371/journal.pone.0017184]
83. Streutker CJ, Bernstein CN, Chan VL, Riddell RH, Croitoru K. Detection of species-specific helicobacter ribosomal DNA in intestinal biopsy samples from a population-based cohort of patients with ulcerative colitis. J Clin Microbiol 2004; 42: 660-664 [PMID: 14766833]
84. Bell SJ, Chisholm SA, Owen RJ, Borriello SP, Kamm MA. Evaluation of Helicobacter species in inflammatory bowel disease. Aliment Pharmacol Ther 2003; 18: 481-486 [PMID: 12950420]
85. Huijsdens XW, Linskens RK, Koppes J, Tang YL, Meuwissen SG, Vandenbroucke-Grauls CM, Savelkoul PH. Detection of Helicobacter species DNA by quantitative PCR in the gastrointestinal tract of healthy individuals and of patients with inflammatory bowel disease. FEMS Immunol Med Microbiol 2004; 41: 79-84 [PMID: 15094170]
86. Basset C, Holton J, Bazeos A, Vaira D, Bloom S. Are Helicobacter species and enterotoxigenic Bacteroides fragilis involved in inflammatory bowel disease? Dig Dis Sci 2004; 49: 1425-1432 [PMID: 15481314]
87. Sturegård E, Hertervig E, Sjunnesson H, Wadström T. Helicobacter species in human colon biopsies. Aliment Pharmacol Ther 2004; 19: 613-614 [PMID: 14987330]
88. Grehan M, Danon S, Lee A, Daskalopoulos G, Mitchell H. Absence of mucosa-associated colonic Helicobacters in an Australian urban population. J Clin Microbiol 2004; 42: 874-876 [PMID: 14766877 DOI: 10.1128/JCM.42.2.874-876.2004]
89. Ruuska T, Vaajalahti P, Arajärvi P, Mäki M. Prospective evaluation of upper gastrointestinal mucosal lesions in children with ulcerative colitis and Crohn's disease. J Pediatr Gastroenterol Nutr 1994; 19: 181-186 [PMID: 7815240]
90. Püspök A, Dejaco C, Oberhuber G, Waldhör T, Hirschl AM, Vogelsang H, Gasche C. Influence of Helicobacter pylori infection on the phenotype of Crohn's disease. Am J Gastroenterol 1999; 94: 3239-3244 [PMID: 10566722]
91. Smoot DT, Mobley HL, Chippendale GR, Lewison JF, Resau JH. Helicobacter pylori urease activity is toxic to human gastric epithelial cells. Infect Immun 1990; 58: 1992-1994 [PMID: 2341188]
92. Negrini R, Lisato L, Zanella I, Cavazzini L, Gullini S, Villanacci V, Poiesi C, Albertini A, Ghielmi S. Helicobacter pylori infection induces antibodies cross-reacting with human gastric mucosa. Gastroenterology 1991; 101: 437-445 [PMID: 2065920]
93. Elizalde JI, Gómez J, Panés J, Lozano M, Casadevall M, Ramírez J, Pizcueta P, Marco F, Rojas FD, Granger DN, Piqué JM. Platelet activation In mice and human Helicobacter pylori infection. J Clin Invest 1997; 100: 996-1005 [PMID: 9276716]
94. Duchmann R, Märker-Hermann E, Meyer zum Büschenfelde KH. Bacteria-specific T-cell clones are selective in their reactivity towards different enterobacteria or H. pylori and increased in inflammatory bowel disease. Scand J Immunol 1996; 44: 71-79 [PMID: 8693294]
95. Farmer RG, Whelan G, Fazio VW. Long-term follow-up of patients with Crohn's disease. Relationship between the clinical pattern and prognosis. Gastroenterology 1985; 88: 1818-1825 [PMID: 3922845]
96. Thomas JE, Whatmore AM, Barer MR, Eastham EJ, Kehoe MA. Serodiagnosis of Helicobacter pylori infection in childhood. J Clin Microbiol 1990; 28: 2641-2646 [PMID: 2279995]
97. Luther J, Dave M, Higgins PD, Kao JY. Association between Helicobacter pylori infection and inflammatory bowel disease: a meta-analysis and systematic review of the literature. Inflamm Bowel Dis 2010; 16: 1077-1084 [PMID: 19760778 DOI: 10.1002/ibd.21116]
98. Genta RM, Sonnenberg A. Non-Helicobacter pylori gastritis is common among paediatric patients with inflammatory bowel disease. Aliment Pharmacol Ther 2012; 35: 1310-1316 [PMID: 22486730 DOI: 10.1111/j.1365-2036.2012.05090.x]
99. Guslandi M, Fanti L, Testoni PA. Helicobacter pylori seroprevalence in Crohn's disease: lack of influence by pharmacological treatment. Hepatogastroenterology 2002; 49: 1296-1297 [PMID: 12239929]
100. Ishikawa N, Fuchigami T, Matsumoto T, Kobayashi H, Sakai Y, Tabata H, Takubo N, Yamamoto S, Nakanishi M, Tomioka K, Fujishima M. Helicobacter pylori infection in rheumatoid arthritis: effect of drugs on prevalence and correlation with gastroduodenal lesions. Rheumatology (Oxford) 2002; 41: 72-77 [PMID: 11792883]
101. Taha AS, Sturrock RD, Russell RI. Helicobacter pylori and peptic ulcers in rheumatoid arthritis patients receiving gold, sulfasalazine, and nonsteroidal anti-inflammatory drugs. Am J Gastroenterol 1992; 87: 1732-1735 [PMID: 1360191]
102. Stenson WF, Mehta J, Spilberg I. Sulfasalazine inhibition of binding of N-formyl-methionyl-leucyl-phenylalanine (FMLP) to its receptor on human neutrophils. Biochem Pharmacol 1984; 33: 407-412 [PMID: 6142713]
103. Comer SS, Jasin HE. In vitro immunomodulatory effects of sulfasalazine and its metabolites. J Rheumatol 1988; 15: 580-586 [PMID: 2899646]
104. Sousa LS, Santos AM, Macedo TC, Pinto AS, Sousa AC, Reis J, Va S, Quina MG. Prevalence of H. pylori (Hp) infection in inflammatory bowel disease (IBD): A controlled study. Gut 1996; 39 suppl 2: A94-A95
105. Guslandi M. More about Helicobacter pylori, antibiotics and IBD. Helicobacter 2004; 9: 469author reply 469-470 [PMID: 15361088]
106. Chen Y, Blaser MJ. Inverse associations of Helicobacter pylori with asthma and allergy. Arch Intern Med 2007; 167: 821-827 [PMID: 17452546]
107. Parronchi P, Romagnani P, Annunziato F, Sampognaro S, Becchio A, Giannarini L, Maggi E, Pupilli C, Tonelli F, Romagnani S. Type 1 T-helper cell predominance and interleukin- 12 expression in the gut of patients with Crohn's disease. Am J Pathol 1997; 150: 823-832 [PMID: 9060820]
108. Fuss IJ, Neurath M, Boirivant M, Klein JS, de la Motte C, Strong SA, Fiocchi C, Strober W. Disparate CD4+ lamina propria (LP) lymphokine secretion profiles in inflammatory bowel disease. Crohn's disease LP cells manifest increased secretion of IFN-gamma, whereas ulcerative colitis LP cells manifest increased secretion of IL-5. J Immunol 1996; 157: 1261-1270 [PMID: 8757634]
109. Supajatura V, Ushio H, Wada A, Yahiro K, Okumura K, Ogawa H, Hirayama T, Ra C. Cutting edge: VacA, a vacuolating cytotoxin of Helicobacter pylori, directly activates mast cells for migration and production of proinflammatory cytokines. J Immunol 2002; 168: 2603-2607 [PMID: 11884423]
110. Asahi M, Azuma T, Ito S, Ito Y, Suto H, Nagai Y, Tsubokawa M, Tohyama Y, Maeda S, Omata M, Suzuki T, Sasakawa C. Helicobacter pylori CagA protein can be tyrosine phosphorylated in gastric epithelial cells. J Exp Med 2000; 191: 593-602 [PMID: 10684851]
111. Yakabi K, Ro S, Okazaki R, Shiojima J, Tsuda K, Mimura H, Tomono H, Nakamura T. Water extract of Helicobacter pylori stimulates interleukin-8 secretion by a human gastric epithelial cell line (JR-St) through protein tyrosine phosphorylation. J Gastroenterol Hepatol 2000; 15: 263-270 [PMID: 10764026]
112. Banchereau J, Briere F, Caux C, Davoust J, Lebecque S, Liu YJ, Pulendran B, Palucka K. Immunobiology of dendritic cells. Annu Rev Immunol 2000; 18: 767-811 [PMID: 10837075]
113. Guiney DG, Hasegawa P, Cole SP. Helicobacter pylori preferentially induces interleukin 12 (IL-12) rather than IL-6 or IL-10 in human dendritic cells. Infect Immun 2003; 71: 4163-4166 [PMID: 12819109]
114. D'Elios MM, Manghetti M, Almerigogna F, Amedei A, Costa F, Burroni D, Baldari CT, Romagnani S, Telford JL, Del Prete G. Different cytokine profile and antigen-specificity repertoire in Helicobacter pylori-specific T cell clones from the antrum of chronic gastritis patients with or without peptic ulcer. Eur J Immunol 1997; 27: 1751-1755 [PMID: 9247587]
115. Mottet C, Uhlig HH, Powrie F. Cutting edge: cure of colitis by CD4+CD25+ regulatory T cells. J Immunol 2003; 170: 3939-3943 [PMID: 12682220]
116. Read S, Malmström V, Powrie F. Cytotoxic T lymphocyteassociated antigen 4 plays an essential role in the function of CD25(+)CD4(+) regulatory cells that control intestinal inflammation. J Exp Med 2000; 192: 295-302 [PMID: 10899916]
117. De Winter H, Cheroutre H, Kronenberg M. Mucosal immunity and inflammation. II. The yin and yang of T cells in intestinal inflammation: pathogenic and protective roles in a mouse colitis model. Am J Physiol 1999; 276: G1317-G1321 [PMID: 10362634]
118. Izcue A, Coombes JL, Powrie F. Regulatory T cells suppress systemic and mucosal immune activation to control intestinal inflammation. Immunol Rev 2006; 212: 256-271 [PMID: 16903919]
119. Gad M. Regulatory T cells in experimental colitis. Curr Top Microbiol Immunol 2005; 293: 179-208 [PMID: 15981481]
120. Lundgren A, Suri-Payer E, Enarsson K, Svennerholm AM, Lundin BS. Helicobacter pylori-specific CD4+ CD25high regulatory T cells suppress memory T-cell responses to H. pylori in infected individuals. Infect Immun 2003; 71: 1755-1762 [PMID: 12654789]
121. Kandulski A, Wex T, Kuester D, Peitz U, Gebert I, Roessner A, Malfertheiner P. Naturally occurring regulatory T cells (CD4+, CD25high, FOXP3+) in the antrum and cardia are associated with higher H. pylori colonization and increased gene expression of TGF-beta1. Helicobacter 2008; 13: 295-303 [PMID: 18665940 DOI: 10.1111/j.1523-5378.2008.00612.x]
122. Kao JY, Rathinavelu S, Eaton KA, Bai L, Zavros Y, Takami M, Pierzchala A, Merchant JL. Helicobacter pylori-secreted factors inhibit dendritic cell IL-12 secretion: a mechanism of ineffective host defense. Am J Physiol Gastrointest Liver Physiol 2006; 291: G73-G81 [PMID: 16469828]
123. Kao JY, Zhang M, Miller MJ, Mills JC, Wang B, Liu M, Eaton KA, Zou W, Berndt BE, Cole TS, Takeuchi T, Owyang SY, Luther J. Helicobacter pylori immune escape is mediated by dendritic cell-induced Treg skewing and Th17 suppression in mice. Gastroenterology 2010; 138: 1046-1054 [PMID: 19931266 DOI: 10.1053/j.gastro.2009.11.043]
124. Leach MW, Davidson NJ, Fort MM, Powrie F, Rennick DM. The role of IL-10 in inflammatory bowel disease: "of mice and men". Toxicol Pathol 1999; 27: 123-133 [PMID: 10367687]
125. Luther J, Owyang SY, Takeuchi T, Cole TS, Zhang M, Liu M, Erb-Downward J, Rubenstein JH, Chen CC, Pierzchala AV, Paul JA, Kao JY. Helicobacter pylori DNA decreases pro-inflammatory cytokine production by dendritic cells and attenuates dextran sodium sulphate-induced colitis. Gut 2011; 60: 1479-1486 [PMID: 21471567 DOI: 10.1136/gut.2010.220087]
126. Higgins PD, Johnson LA, Luther J, Zhang M, Sauder KL, Blanco LP, Kao JY. Prior Helicobacter pylori infection ameliorates Salmonella typhimurium-induced colitis: mucosal crosstalk between stomach and distal intestine. Inflamm Bowel Dis 2011; 17: 1398-1408 [PMID: 21560200 DOI: 10.1002/ ibd.21489]
127. Newell DG. Identification of the outer membrane proteins of Campylobacter pyloridis and antigenic cross-reactivity between C. pyloridis and C. jejuni. J Gen Microbiol 1987; 133: 163-170 [PMID: 3309141]
128. Tindberg Y, Bengtsson C, Bergström M, Granström M. The accuracy of serologic diagnosis of Helicobacter pylori infection in school-aged children of mixed ethnicity. Helicobacter 2001; 6: 24-30 [PMID: 11328362]
129. Blaser MJ. Epidemiologic and clinical features of Campylobacter jejuni infections. J Infect Dis 1997; 176 Suppl 2: S103-S105 [PMID: 9396691]
130. Lemke LB, Ge Z, Whary MT, Feng Y, Rogers AB, Muthupalani S, Fox JG. Concurrent Helicobacter bilis infection in C57BL/6 mice attenuates proinflammatory H. pyloriinduced gastric pathology. Infect Immun 2009; 77: 2147-2158 [PMID: 19223483 DOI: 10.1128/IAI.01395-08]
131. Elliott DE, Urban JF JR, Argo CK, Weinstock JV. Does the failure to acquire helminthic parasites predispose to Crohn's disease? FASEB J 2000; 14: 1848-1855 [PMID: 10973934]
132. Mendall MA, Goggin PM, Molineaux N, Levy J, Toosy T, Strachan D, Northfield TC. Childhood living conditions and Helicobacter pylori seropositivity in adult life. Lancet 1992; 339: 896-897 [PMID: 1348299]
133. Amre DK, Lambrette P, Law L, Krupoves A, Chotard V, Costea F, Grimard G, Israel D, Mack D, Seidman EG. Investigating the hygiene hypothesis as a risk factor in pediatric onset Crohn's disease: a case-control study. Am J Gastroenterol 2006; 101: 1005-1011 [PMID: 16573775 DOI: 10.1111/ j.1572-0241.2006.00526.x]
134. Kelly D, Conway S, Aminov R. Commensal gut bacteria: mechanisms of immune modulation. Trends Immunol 2005; 26: 326-333 [PMID: 15922949]
135. Raju D, Hussey S, Ang M, Terebiznik MR, Sibony M, Galindo- Mata E, Gupta V, Blanke SR, Delgado A, Romero-Gallo J, Ramjeet MS, Mascarenhas H, Peek RM, Correa P, Streutker C, Hold G, Kunstmann E, Yoshimori T, Silverberg MS, Girardin SE, Philpott DJ, El Omar E, Jones NL. Vacuolating cytotoxin and variants in Atg16L1 that disrupt autophagy promote Helicobacter pylori infection in humans. Gastroenterology 2012; 142: 1160-1171 [PMID: 22333951 DOI: 10.1053/ j.gastro.2012.01.043]
136. Tursi A. Onset of Crohn's disease after Helicobacter pylori eradication. Inflamm Bowel Dis 2006; 12: 1008-1009 [PMID: 17012975]
137. Jovanovic IR, Milosavjevic TN, Jankovic GP, Micev MM, Dugalic PD, Saranovic D, Ugljesic MM, Popovic DV, Bulajic MM. Clinical onset of the Crohn's disease after eradication therapy of Helicobacter pylori infection. Does Helicobacter pylori infection interact with natural history of inflammatory bowel diseases? Med Sci Monit 2001; 7: 137-141 [PMID: 11208510]
138. Zhao YS, Wang F, Chang D, Han B, You DY. Meta-analysis of different test indicators: Helicobacter pylori infection and the risk of colorectal cancer. Int J Colorectal Dis 2008; 23: 875-882 [PMID: 18506454 DOI: 10.1007/s00384-008-0479-z]
139. Kapetanakis N, Kountouras J, Zavos C, Anastasiadou K, Tsarouchas G, Michael S, Gavalas E, Tsiaousi E, Polyzos SA, Venizelos I, Nikolaidou C, Vardaka E. Potential oncogenic properties of mobilized stem cells in a subpopulation of inflammatory bowel disease patients infected with Helicobacter pylori. Inflamm Bowel Dis 2013; 19: E27-E29 [PMID: 22344973 DOI: 10.1002/ibd.22911]
140. Kountouras J, Kouklakis G, Zavos C, Chatzopoulos D, Moschos J, Molyvas E, Zavos N. Apoptosis, inflammatory bowel disease and carcinogenesis: overview of international and Greek experiences. Can J Gastroenterol 2003; 17: 249-258 [PMID: 12704469]
141. Kountouras J, Boura P, Lygidakis NJ. New concepts of molecular biology for colon carcinogenesis. Hepatogastroenterology 2000; 47: 1291-1297 [PMID: 11100335]
142. Kountouras J, Zavos C, Chatzopoulos D. Pathogenetic links between colorectal neoplasia and Barrett's esophagus. Gastrointest Endosc 2006; 64: 298 [PMID: 16860098]
143. Sonnenberg A, Genta RM. Helicobacter pylori is a risk factor for colonic neoplasms. Am J Gastroenterol 2013; 108: 208-215 [PMID: 23208272 DOI: 10.1038/ajg.2012.407]
144. Kountouras J, Chatzopoulos D, Zavos C. Reactive oxygen metabolites and upper gastrointestinal diseases. Hepatogastroenterology 2001; 48: 743-751 [PMID: 11462918]
145. Triantafillidis JK, Gikas A. Over-time changes of Helicobacter pylori infection rate in patients with inflammatory bowel disease. J Crohns Colitis 2013; 7: 681 [PMID: 23360574 DOI: 10.1016/j.crohns.2013.01.007]
146. Cutler AF, Prasad VM. Long-term follow-up of Helicobacter pylori serology after successful eradication. Am J Gastroenterol 1996; 91: 85-88 [PMID: 8561150]
147. Malfertheiner P, Megraud F, O'Morain CA, Atherton J, Axon AT, Bazzoli F, Gensini GF, Gisbert JP, Graham DY, Rokkas T, El-Omar EM, Kuipers EJ. Management of Helicobacter pylori infection--the Maastricht IV/ Florence Consensus Report. Gut 2012; 61: 646-664 [PMID: 22491499 DOI: 10.1136/gutjnl-2012-302084]